UNSPSC 51282209: Flomoxef sodium

This classification denotes a cephalosporin antibiotic with the molecular structure C15H17F2N6O7S2.NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 445HIB8XNF chemically known as 5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((difluoromethyl)thio)acetyl)amino)-3-(((1-(2-hydroxyethyl)-1h-tetrazol-5-yl)thio)methyl)-7-methoxy-8-oxo-, sodium salt (1:1), (6r,7r)-, but more commonly known as flomoxef sodium, which bears US NIH Compound Identifier 443982.

UNSPSC 51282209 Flomoxef sodium is a Commodity code that in recent state and local procurement activity covers a broader range of pharmaceutical products and medical supplies than its nominal title suggests. Recent solicitations under this code show state and local governments procuring naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing, and exploring direct-to-manufacturer prescription programs. Issuing bodies include county health departments (Seminole County, Florida), municipal fire and rescue divisions (City of Tampa Fire Department), state health and human services agencies (Texas HHS Commission), and regional cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). The code reflects procurement of finished pharmaceutical products, emergency medical consumables, and wholesale distribution arrangements rather than chemical or active pharmaceutical ingredients at the manufacturing stage.

Recent opportunities span Florida, Texas, Minnesota, and Oregon. The Seminole County IFB (IFB60459723LAS, due July 26, 2023) seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries. The City of Tampa IFB (26P00145, due March 13, 2026) covers 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000 and a 5 percent bid discount available for certified Small Local Business Enterprises. The Minnesota Multistate Cooperative Purchasing Alliance RFP (S1070000015802, due March 26, 2026) establishes multiple contracts for generic pharmaceuticals and OTC products distributed through authorized wholesalers, effective July 1, 2026. The Texas HHS Commission issued an RFI (HHS0017013, posted April 3, 2026) to gather market intelligence on direct-to-manufacturer prescription programs before issuing a formal RFP. Geographic and issuing-body diversity suggests this code activity spans state procurement offices, county health departments, municipal purchasing, and cooperative purchasing vehicles across multiple regions.